进阶性躯干稳定训练对腰椎融合术后居家康复的疗效观察

注册号:

Registration number:

ChiCTR2300072336 

最近更新日期:

Date of Last Refreshed on:

2023-07-25 08:24:49 

注册时间:

Date of Registration:

2023-06-09 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

进阶性躯干稳定训练对腰椎融合术后居家康复的疗效观察

Public title:

Effect of advanced trunk stabilization training on home rehabilitation after lumbar fusion surgery

注册题目简写:

English Acronym:

研究课题的正式科学名称:

进阶性躯干稳定训练对腰椎融合术后居家康复的疗效观察

Scientific title:

Effect of advanced trunk stabilization training on home rehabilitation after lumbar fusion surgery

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

施捷健 

研究负责人:

施捷健 

Applicant:

Jiejian Shi 

Study leader:

Jiejian Shi 

申请注册联系人电话:

Applicant telephone:

+86 138 1807 9637

研究负责人电话:

Study leader's
telephone:

+86 138 1807 9637

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

shijiejian@163.com

研究负责人电子邮件:

Study leader's E-mail:

shijiejian@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市黄浦区瞿溪路1100号

研究负责人通讯地址:

上海市黄浦区瞿溪路1100号

Applicant address:

1100 Quxi Road, Huangpu District, Shanghai

Study leader's address:

1100 Quxi Road, Huangpu District, Shanghai

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海市瑞金康复医院

Applicant's institution:

Shanghai Ruijin Rehabilitation Hospital

研究负责人所在单位:

上海市瑞金康复医院

Affiliation of the Leader:

Shanghai Ruijin Rehabilitation Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

RKIRB2023-05

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海市瑞金康复医院伦理委员会

Name of the ethic committee:

Ethics Committee of Shanghai Ruijin Rehabilitation Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2023-02-06 00:00:00

伦理委员会联系人:

徐丁婷

Contact Name of the ethic committee:

Dingting Xu

伦理委员会联系地址:

上海市黄浦区瞿溪路1100号

Contact Address of the ethic committee:

1100 Quxi Road, Huangpu District, Shanghai

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 21 6303 7638

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海市瑞金康复医院

Primary sponsor:

Shanghai Ruijin Rehabilitation Hospital

研究实施负责(组长)单位地址:

上海市黄浦区瞿溪路1100号

Primary sponsor's address:

1100 Quxi Road, Huangpu District, Shanghai

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市瑞金康复医院

具体地址:

上海市黄浦区瞿溪路1100号

Institution
hospital:

Shanghai Ruijin Rehabilitation Hospital

Address:

1100 Quxi Road, Huangpu District, Shanghai

经费或物资来源:

自筹

Source(s) of funding:

self-financing

研究疾病:

腰椎融合术后  

Target disease:

lumbar fusion surgery

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

此实验目的是探索腰椎融合术后居家康复的优化方式,帮助基层缓解康复资源不足的问题,解决四级网络康复中居家康复的实施困难问题。节约腰椎融合术康复成本,提高患者康复治疗积极性,提高腰椎融合术患者康复疗效,增加腰椎融合术社区康复的资源,帮助解决康复供需矛盾,最终使康复工作真正步入社区走进家庭。  

Objectives of Study:

The purpose of this experiment is to explore the optimal way of home rehabilitation after lumbar fusion, help the grassroots to alleviate the problem of inadequate rehabilitation resources, and solve the difficulty of home rehabilitation implementation in the four-level network rehabilitation. It can save the rehabilitation cost of lumbar fusion, improve the enthusiasm of patients for rehabilitation treatment, improve the rehabilitation effect of patients with lumbar fusion, increase the resources of community rehabilitation of lumbar fusion, help solve the contradiction between supply and demand of rehabilitation, and finally make the rehabilitation work truly enter the community into the family.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

( 1 ) 多发性骨折;( 2 ) 合并感染者;( 3 ) 合并骨质疏松;( 4 ) 拒绝加入本研究;( 5 ) 合并严重血栓;( 6 ) 合并严重的心脑血管并发症;

Exclusion criteria:

(1) Multiple fractures; (2) Co-infected persons; (3) Combined with osteoporosis; (4) Refuse to join the study; (5) Severe thrombosis; (6) Complicated with serious cardiovascular and cerebrovascular complications.

研究实施时间:

Study execute time:

From 2023-01-01 00:00:00 To 2025-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-07-01 00:00:00 To 2024-06-30 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

30

Group:

Observation group

Sample size:

干预措施:

采用常规康复治疗结合20至24周的进阶性居家康复训练

干预措施代码:

Intervention:

Conventional rehabilitation therapy combined with 20 to 24 weeks of advanced home rehabilitation training was used.

Intervention code:

组别:

对照组

样本量:

30

Group:

Control group

Sample size:

干预措施:

常规康复治疗及居家延续常规康复治疗内容

干预措施代码:

Intervention:

Routine rehabilitation therapy and home continuation of routine rehabilitation therapy.

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市瑞金康复医院 

单位级别:

二级乙等 

Institution
hospital:

Shanghai Ruijin Rehabilitation Hospital

Level of the institution:

Secondary B

测量指标:

Outcomes:

指标中文名:

视觉模拟评分

指标类型:

主要指标

Outcome:

visual analogue scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Oswestry 功能障碍指数

指标类型:

主要指标

Outcome:

oswestry disability index

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

日本骨科学会

指标类型:

主要指标

Outcome:

Japanese orthopaedic association

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肌电图

指标类型:

次要指标

Outcome:

electromyography

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

康复治疗花费

指标类型:

次要指标

Outcome:

Rehabilitation treatment expenses

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

Not have

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 95 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数字表法

Randomization Procedure (please state who generates the random number sequence and by what method):

Random number table method

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Not have

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2023-06-09 17:40:33